With a 30-minute half-life on the CJC-1295 (No DAC) side, spacing the two several hours apart means the GHRH signal has largely cleared before the ghrelin signal is working and the supra-additive effect is what you lose
If you are considering these treatments, consult with a medical professional experienced in hormone therapy to determine the optimal approach for your specific needs.

Research has examined its role in: GH secretion stimulation via selective GHS-R1a agonism IGF-1 axis modulation and downstream anabolic signalling research Longitudinal bone growth and bone mineral content investigations Body composition and lean tissue research in pre-clinical models Comparative GHRP selectivity and receptor-binding studies Postoperative gastrointestinal motility research via ghrelin receptor pathways Synergistic GH axis research when combined with GHRH analogues such as CJC-1295 Ipamorelin and Longitudinal Bone Growth Research In adult female rats administered Ipamorelin subcutaneously three times daily for 15 days, a dose-dependent increase in longitudinal bone growth rate was observed rising from 42 m/day in the vehicle group to 52 m/day at the highest dose confirming GH-mediated effects on skeletal tissue in pre-clinical models
before bedtime Patients can inject the lower part of the stomach, thigh, or upper arm
BENEFITS/ CLINICAL TRIALS The research interest in IGF-1 LR3 is primarily focused on its enhanced anabolic (tissue-building) and lipolytic (fat-burning) potency compared to the native hormone
HRT helps maintain muscle mass and reduces the risk of osteoporosis